CS logo
small CS logo
Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly

Gyor, Hungary
Hospital in Győr
Győr, Vasvári Pál u. 2-4, 9024

About Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Institut de Recherches Internationales Servier
2
Pfizer
2
Hoffmann-La Roche
1
Phytopharm
1
Taiho Oncology, Inc.
1
Total Rows: 5

Clinical Trials at Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


During the past decade, Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000011221111000000Started TrialsCompleted Trails201620172018201920200123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Investigation of Cogane (PYM50028) in Early-stage Parkinson's Disease (CONFIDENT-PD)
2010-11-01
2012-12-01
Completed
425
Study Evaluating The Safety And Efficacy Of PF-03049423 In Subjects With Ischemic Stroke
2010-12-01
2013-12-01
Terminated
181
A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)
2013-02-22
2023-08-26
Active, not recruiting
666
Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event
2016-12-19
2019-03-10
Completed
585
Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.
2019-03-21
2022-10-01
Completed
874
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
2020-12-03
2029-09-06
Recruiting
699
Phase III Study of Trifluridine/Tipiracil in Combination With Bevacizumab vs Trifluridine/Tipiracil Single Agent in Patients With Refractory Metastatic Colorectal Cancer
2020-11-25
2023-09-01
Active, not recruiting
490

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" #1 sponsor was "Institut de Recherches Internationales Servier" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Phytopharm" with 1 trials sponsored and "Taiho Oncology, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator and "Institut de Recherches Internationales Servier" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstitut de RecherchesInternationales Servier:2Institut de RecherchesInternationales Servier:2Pfizer: 2Pfizer: 2Hoffmann-La Roche: 1Hoffmann-La Roche: 1Phytopharm: 1Phytopharm: 1Taiho Oncology, Inc.: 1Taiho Oncology, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsADIR, a Servier Groupcompany: 2ADIR, a Servier Groupcompany: 2Institut de RecherchesInternationales Servier:1Institut de RecherchesInternationales Servier:1

Clinical Trials Conditions at Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


According to Clinical.Site data, the most researched conditions in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" are "Breast Neoplasms" (1 trials), "Ischemic Stroke" (1 trials), "Metastatic Colorectal Cancer" (1 trials), "Multiple Sclerosis" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" in a lesser frequency.

Clinical Trials Intervention Types at Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


Most popular intervention types in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Antihistamine" (1 trials), "Bevacizumab" (1 trials), "Bevacizumab control" (1 trials) and "Bevacizumab experimental" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


The vast majority of trials in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly


Currently, there are NaN active trials in "Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Petz Aladar Megyei Oktato Korhaz Neurologiai Osztaly, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 3Phase 2: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1